OraDisc A Access Pharmaceuticals, Inc. - Treatment for Aphthous Ulcers
OraDisc A is a mucoadhesive patch which gradually erodes and releases the active drug amlexanox when applied to the inside of the mouth. Oradisc A is approved for the treatment of aphthous ulcers in adults and adolescents 12 years of age and older with a normal immune system.Posted: September 2004
Related articles
- Access’ OraDisc A NDA Accepted For Filing - February 19, 2004
OraDisc A (amlexanox) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
